asp1893
CLDN6-positive Solid Tumor
Astellas Pharma Global Development, Inc.Phase 1
—
Rating in progress
asp1893 in CLDN6-positive Solid Tumor is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.
Methodology v0.2 · Active